HUMAW

These are publicly traded warrants issued by Humacyte, Inc., granting holders the right to purchase common stock of HUMA at a predetermined exercise price before the warrant expiration date. Each warrant typically entitles the holder to buy one share of Humacyte common stock, though specific terms are defined in the warrant agreement. Warrants are derivative securities that provide leveraged exposure to price movements in the underlying common stock. They are speculative instruments that can expire worthless if the common stock price does not exceed the exercise price by expiration, and investors should understand the risks including total loss of investment and dilution effects on existing shareholders when warrants are exercised.